Search for: "SELLERS v. WYETH" Results 21 - 40 of 66
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Mar 2013, 2:00 pm by Bexis
  Section 402A also expanded the scope of possible liable parties to also include all sellers in the distribution process related to the dissemination of the product to the public at large. [read post]
26 Mar 2013, 9:35 am by Daniel E. Cummins
Wyeth, 15 A.3d 429 (Pa. 2011)(Court granted allocatur to address appeal in products liability case;  this appeal may represent another opportunity for the Pennsylvania Supreme Court to revisit the Restatement (Second) versus (Third) debate and finally clarify the issue).U.S. [read post]
21 Nov 2012, 5:00 am by Bexis
Wyeth-Ayerst Labs., 385 F.3d 961, 966 (6th Cir. 2004) (holding that a drug manufacturer is immune from suit unless “the FDA itself determines that a fraud has been committed on the agency during the regulatory-approval process”) citing Buckman Co. v. [read post]
18 Jun 2012, 6:51 am by Rebecca Tushnet
Wyeth-Ayerst Laboratories, 283 F.3d 315 (5th Cir. 2002), and  Williams v. [read post]
11 Aug 2011, 1:09 pm by Bexis
  In section 11 recall-related liability is recognized only in limited situations after a recall has already otherwise been instituted:One engaged in the business of selling or otherwise distributing products is subject to liability for harm to persons or property caused by the seller's failure to recall a product after the time of sale or distribution if:(a)(1) a governmental directive issued pursuant to a statute or administrative regulation specifically requires the… [read post]
29 Jun 2011, 5:00 am by Bexis
  For the reasons why other courts disagree, we recommend reading Alm v. [read post]
28 Apr 2011, 3:18 pm by Bexis
  Going beyond the terms of comment k, the Idaho court next decreed that “a seller next must establish that the product’s risk is in fact ‘unavoidable. [read post]